中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2014年
18期
126-128
,共3页
尿蛋白电泳%肾脏病%临床评价
尿蛋白電泳%腎髒病%臨床評價
뇨단백전영%신장병%림상평개
Urine protein electrophoresis%Kidney disease%Clinical evaluation
目的探讨尿蛋白电泳测定及临床应用。方法选取临床26例肾脏病患者尿蛋白电泳检测的临床应用。结果生理性蛋白分子量65～70 kda 3例，肾小球性蛋白尿≥65～70 kda 11例，肾小球性蛋白尿<65 kda 6例，混合性蛋白尿<65 kda和混合性蛋白尿≥65～70 kda 5例。结论通过尿蛋白电泳检测确定尿蛋白的来源；了解肾脏病变的严重程序（选择性蛋白尿与非选择性蛋白尿），从而有助于诊断和预后的判断。
目的探討尿蛋白電泳測定及臨床應用。方法選取臨床26例腎髒病患者尿蛋白電泳檢測的臨床應用。結果生理性蛋白分子量65～70 kda 3例，腎小毬性蛋白尿≥65～70 kda 11例，腎小毬性蛋白尿<65 kda 6例，混閤性蛋白尿<65 kda和混閤性蛋白尿≥65～70 kda 5例。結論通過尿蛋白電泳檢測確定尿蛋白的來源；瞭解腎髒病變的嚴重程序（選擇性蛋白尿與非選擇性蛋白尿），從而有助于診斷和預後的判斷。
목적탐토뇨단백전영측정급림상응용。방법선취림상26례신장병환자뇨단백전영검측적림상응용。결과생이성단백분자량65～70 kda 3례，신소구성단백뇨≥65～70 kda 11례，신소구성단백뇨<65 kda 6례，혼합성단백뇨<65 kda화혼합성단백뇨≥65～70 kda 5례。결론통과뇨단백전영검측학정뇨단백적래원；료해신장병변적엄중정서（선택성단백뇨여비선택성단백뇨），종이유조우진단화예후적판단。
Objective Evaluating on urinary protein electrophoresis and its clinical applications.Methods selecting 26 urinary protein samples from patients with kidney disease, then making an electrophoresis experiment and applying them clinically.Results For all the samples, 3 of them are categorized as physiological urinary protein with 65~70 kda. 11 of them are glomerular urinary protein with more than 65 but less than 70 kda.6 samples with less than 65 kda, and 5 samples are mixed urinary protein with more than 65 but less than 70 kda.Conclusion Urinary protein electrophoresis clarifies the source of urinary protein as well as the degree of kidney lesions, which would be beneficial for the judgment of diagnosis and prognosis.
